GlassScriptPhysician profile
Ralph Vosburg
NPI 1184927774
$30,555.91
in general payments reported to CMS, 2019-2025
20 companies · $4,557 in 2025
The $4,557 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,149 · 2020: $85.84 · 2021: $2,884 · 2022: $13K · 2023: $8,227 · 2024: $399 · 2025: $4,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Travel and Lodging: $3,204 · Food and Beverage: $2,148 · Consulting Fee: $1,815 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Travel and Lodging | $3,204.00 |
| Food and Beverage | $2,148.03 |
| Consulting Fee | $1,815.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,307.64 | 2021-2025 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $3,782.79 | 2021-2025 | Signia, V-Loc 180, Endoflip |
| Davol INC. | $2,431.63 | 2022-2025 | Phasix Mesh |
| Medical Device Business Services, INC. | $952.99 | 2019 | |
| Bolder Surgical, LLC | $675.00 | 2023 | Coolseal Generator |
| Ethicon US, LLC | $600.89 | 2019-2024 | Echelon Endopath, Echelon Flex, Echelon Circular |
| Novo Nordisk INC | $192.68 | 2019-2025 | Wegovy |
| Amgen INC. | $147.32 | 2020-2023 | Evenity, Prolia |
| Phathom Pharmaceuticals, INC. | $136.34 | 2025 | Voquezna |
| Becton, Dickinson and Company | $83.04 | 2023 | Phasix Mesh, Bard 3dmax Mesh |
| Vantive US Healthcare LLC | $54.56 | 2025 | Renal - Pd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.87 | 2019-2023 | Jardiance |
| Lilly USA, LLC | $22.95 | 2024 | Zepbound, Jardiance |
| Tela Bio, INC. | $22.11 | 2024 | Ovitex 2s |
| Abbott Laboratories | $21.46 | 2023 | Freestyle Libre 3 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $17.82 | 2022 | |
| Endo Pharmaceuticals INC. | $15.54 | 2019 | |
| Dexcom, INC. | $13.05 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.15 | 2022 | |
| Merck Sharp & Dohme LLC | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Vosburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.